Telix Pharmaceuticals (TLX) Stock Chart & Stock Price History $10.82 -0.07 (-0.64%) Closing price 08/12/2025 04:00 PM EasternExtended Trading$11.07 +0.25 (+2.30%) As of 08/12/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Telix Pharmaceuticals Stock Price Performance The Telix Pharmaceuticals (TLX) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 29.74%. In the past month, the stock has decreased 32.25%, reflecting recent market activity. As of the latest close, Telix Pharmaceuticals traded at $10.82 with a market cap of $3.66 billion and volume of 111,788 shares. Receive TLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.59%1 Month Performance-32.25%3 Month Performance-35.25%Year-To-Date Performance-29.74% TLX Stock Chart for Wednesday, August, 13, 2025 TLX Chart by TradingView Telix Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/12/2025$10.89$10.82-0.64%$10.98$10.70111,788 shs$3.66 billion08/11/2025$11.34$10.89-3.97%$11.20$10.8682,399 shs$3.69 billion08/08/2025$11.78$11.34-3.74%$11.67$11.34155,231 shs$3.84 billion08/07/2025$11.97$11.78-1.59%$12.00$11.7031,511 shs$3.99 billion08/06/2025$12.26$11.97-2.37%$12.25$11.83134,910 shs$4.05 billion08/05/2025$13.32$12.26-7.96%$12.37$12.1098,547 shs$4.15 billion08/04/2025$13.05$13.32+2.07%$14.27$13.2156,825 shs$4.51 billion08/01/2025$13.59$13.05-3.97%$13.19$12.9055,378 shs$4.42 billion07/31/2025$13.50$13.59+0.67%$14.17$13.5138,044 shs$4.60 billion07/30/2025$13.49$13.50+0.07%$13.65$13.2552,434 shs$4.57 billion Get the Latest News and Ratings for TLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/29/2025$13.96$13.49-3.37%$13.79$13.3552,138 shs$4.57 billion07/28/2025$14.20$13.96-1.69%$13.98$13.7984,855 shs$4.72 billion07/25/2025$13.89$14.20+2.23%$14.24$13.8876,204 shs$4.81 billion07/24/2025$14.58$13.89-4.73%$14.39$13.87129,181 shs$4.70 billion07/23/2025$16.28$14.58-10.44%$14.81$14.20227,228 shs$4.93 billion07/22/2025$16.50$16.28-1.33%$16.94$16.0050,928 shs$5.51 billion07/21/2025$16.23$16.50+1.66%$16.60$16.3273,300 shs$5.58 billion07/18/2025$16.14$16.23+0.56%$16.43$15.8013,127 shs$5.49 billion07/17/2025$15.67$16.14+3.00%$16.26$15.7423,746 shs$5.46 billion07/16/2025$15.53$15.67+0.90%$15.79$15.506,883 shs$5.30 billion07/15/2025$15.57$15.53-0.26%$15.90$15.4220,266 shs$5.26 billion07/14/2025$15.97$15.57-2.50%$16.05$15.5036,546 shs$5.27 billion Related Companies TEVA Stock Price Chart GMAB Stock Price Chart RDY Stock Price Chart QGEN Stock Price Chart MRNA Stock Price Chart ASND Stock Price Chart VTRS Stock Price Chart BBIO Stock Price Chart VRNA Stock Price Chart BPMC Stock Price Chart Receive TLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TLX) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access